Connect with us

Hi, what are you looking for?

Wednesday, Jun 12, 2024
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


New Jersey court rules Pepsi must cover medical cannabis costs

The decision came after the state’s Supreme Court ruled that employers have to cover medical cannabis expenses despite federal prohibition

New Jersey court rules Pepsi must cover medical pot costs
Photo by VR0 via Wikimedia Commons

A New Jersey appeals court ruled Tuesday that Pepsi Bottling Co. must reimburse a former employee for medical cannabis costs related to his work-related back injury.

The ruling came after a recent New Jersey Supreme Court decision that employers in the state can be compelled to cover medical cannabis expenses despite federal prohibition of the drug under the Controlled Substances Act.

Based on the Supreme Court’s opinion in Vincent Hager v. M&K Construction on April 13, the appellate court panel upheld a workers’ compensation order in December 2019 directing Pepsi Co. to reimburse Brian Calmon for the medical cannabis prescribed for an injury that he sustained on the job.

New Jersey cannabis lawyer Dan McKillop, partner at Scarinci Hollenbeck, said all employers in the Garden State should take note of the court’s decision in a LinkedIn post.

Pepsi Co. filed the appeal on April 14, a day after the Supreme Court’s decision, using the same argument that M&K had put forward in December 2020.

M&K had contended that since New Jersey’s Compassionate Use Medical Cannabis Act runs afoul with the order of the federal Controlled Substances Act, the firm would be subject to potential federal criminal liability for aiding-and-abetting the use of an illegal drug.

The construction company also argued that medical cannabis isn’t reimbursable as reasonable or necessary treatment under the New Jersey Workers’ Compensation Act.

Additionally, M&K asserted that the case fit within an exception to New Jersey’s medical cannabis law’s reimbursement requirement, and therefore Hager had to cover his own costs.

But the Supreme Court unanimously ruled that injured worker Hager presented sufficient evidence that his prescribed medical cannabis treatment was a “reasonable and necessary” treatment under the state’s Workers Compensation Act, as well as the state’s Compassionate Use Act, and thus can compel his employer to reimburse the cost of the drug.

The Supreme Court also concluded that it’s possible for M&K to abide by both the Controlled Substance Act and New Jersey’s Compassionate Use Medical Cannabis Act at the same time.

In the Calmon v. Pepsi case, the New Jersey appellate court panel held up that precedent in their ruling that Pepsi had to cover Calmon’s previous medical cannabis costs.

“Having considered the record and the parties’ arguments, we affirm the December 2, 2019 order issued by Supervising Judge of Workers’ Compensation Eugene Mulvaney based on the Court’s controlling opinion,” the ruling reads.

The decision comes as New Jersey gets ready to set up an adult-use cannabis market by the end of the year.

It also comes during growing hopes from advocates and industry that the federal government could deschedule cannabis from the Controlled Substances Act this year.

In February, Democratic Senators Cory Booker, Ron Wyden and Majority Leader Chuck Schumer promised they would table sweeping legislation early this year that would end the federal prohibition of weed.

On Tuesday, Schumer said in an interview with The Ringer that he and his colleagues will be “introducing our bill shortly.”

The senator said the bill is being written to help communities worst hit by “this ridiculous scheduling of marijuana like it’s like heroin or cocaine.”

He added that he doesn’t plan to jeopardize the major pot bill by advancing a more modest cannabis banking measure first.

Schumer said that his team is working hard to get the support of Republicans and moderate Democrats to ensure it gets passed.

“We’re going to get some support from the right on this as well, we hope, and we’re going to push it,” he said.  “It’s going to take a little while, we’re going to need a mass campaign, but there’s real excitement in the country to do this now.”


Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Jared Gnam on Twitter

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


It will move from being a Schedule I substance to Schedule III

Alternative Energy

TransAlta will secure over 160,000 megawatt-hours (MWh) of electricity derived from renewable sources annually


The multi-state operator received necessary approval from New Jersey's Cannabis Regulatory Commission on Thursday


The commissioners determined the company lacked transparency in communicating with regulators